Work

Good KarMMa Continues for CAR T-Cell Therapy in Earlier Lines of Therapy for Relapsed Refractory Multiple Myeloma

Year: 2023

Type: article

Source: The Hematologist

DOI: 10.1182/hem.v20.4.2023413

Authors: Hamza Hashmi, Saad Z. Usmani

Institutions: Medical University of South Carolina, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4382752182

FWCI:

Cites: 5

Cited by:

Related to: 10